40
Participants
Start Date
March 31, 2017
Primary Completion Date
September 30, 2024
Study Completion Date
September 30, 2024
Palbociclib
Treatment will continue until disease progression, development of unacceptable toxicity, non-compliance, withdrawal of consent by the patient or investigator decision
RECRUITING
Hospital Universitario Virgen del Rocío, Seville
RECRUITING
Hospital de la Santa Creu i Sant Pau, Barcelona
RECRUITING
Hospital Universitari Germans Trias i Pujol, Barcelona
RECRUITING
Institut Català d'Oncología l'Hospitalet, Barcelona
RECRUITING
Complejo Asistencial Universitario de León, León
RECRUITING
Hospital Clínico San Carlos, Madrid
RECRUITING
Hospital General Universitario Gregorio Marañon, Madrid
RECRUITING
Hospital Universitario 12 de Octubre, Madrid
RECRUITING
Hospital Universitario Fundación Jimenez Diaz, Madrid
RECRUITING
Hospital Universitario La Paz, Madrid
RECRUITING
Hospital Universitario Virgen de la Victoria, Málaga
RECRUITING
Hospital Clínico Universitario Virgen de la Arrixaca, Murcia
RECRUITING
Hospital Universitario Central de Asturias, Oviedo
RECRUITING
Hospital Universitari Son Espases, Palma de Mallorca
RECRUITING
Hospital Universitario de Canarias, Santa Cruz de Tenerife
RECRUITING
Complejo Hospitalario Universitario de Santiago, Santiago de Compostela
RECRUITING
Hospital Universitari i Politècnic La Fe, Valencia
RECRUITING
Instituto Valenciano de Oncología, Valencia
RECRUITING
Hospital Universitario Miguel Servet, Zaragoza
Grupo Espanol de Investigacion en Sarcomas
OTHER